Schedule 13G ownership disclosure

REVANCE THERAPEUTICS INC

Security class unavailable · CUSIP: 761330109

Event date: 2021-01-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0070%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-034892
Form type
SC 13G/A
Filer
Essex Woodlands Health Ventures VIII, L.L.C.
CIK
CIK 1632027
Filed
Feb 10, 2021
Reporting period
Jan 20, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub